InnateDB Protein
|
IDBP-42192.6
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
FA2H
|
Protein Name
|
fatty acid 2-hydroxylase
|
Synonyms
|
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000219368
|
InnateDB Gene
|
IDBG-42190 (FA2H)
|
Protein Structure
|
|
Function |
Required for alpha-hydroxylation of free fatty acids and the formation of alpha-hydroxylated sphingolipids. {ECO:0000269PubMed:15337768, ECO:0000269PubMed:17355976}.
|
Subcellular Localization |
Endoplasmic reticulum membrane {ECO:0000269PubMed:15337768}; Multi-pass membrane protein {ECO:0000269PubMed:15337768}. Microsome membrane {ECO:0000269PubMed:15337768}; Multi-pass membrane protein {ECO:0000269PubMed:15337768}.
|
Disease Associations |
Spastic paraplegia 35, autosomal recessive (SPG35) [MIM:612319]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG35 is a complicated form characterized by childhood onset of gait difficulties. It has a rapid progression and many patients become wheelchair-bound as young adults. Patients manifest cognitive decline associated with leukodystrophy. Other variable neurologic features, such as dystonia, optic atrophy, and seizures may also occur. {ECO:0000269PubMed:19068277, ECO:0000269PubMed:20104589, ECO:0000269PubMed:20853438}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
Detected in differentiating cultured keratinocytes (at protein level). Detected in epidermis and cultured keratinocytes. Highly expressed in brain and colon. Detected at lower levels in testis, prostate, pancreas and kidney. {ECO:0000269PubMed:15337768, ECO:0000269PubMed:17355976}.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 1 experimentally validated interaction(s) in this database.
Experimentally validated |
Total |
1
[view]
|
Protein-Protein |
1
[view]
|
Protein-DNA |
0
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
|
|
Molecular Function |
|
Biological Process |
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR001199
Cytochrome b5-like heme/steroid binding domain
IPR006694
Fatty acid hydroxylase
IPR014430
Inositolphosphorylceramide-B hydroxylase
|
PFAM |
PF00173
PF04116
|
PRINTS |
PR00363
|
PIRSF |
PIRSF005149
|
SMART |
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q7L5A8
|
PhosphoSite |
PhosphoSite-
|
TrEMBL |
B7Z8T6
|
UniProt Splice Variant |
|
Entrez Gene |
79152
|
UniGene |
Hs.604736
|
RefSeq |
NP_077282
|
HUGO |
HGNC:21197
|
OMIM |
611026
|
CCDS |
CCDS10911
|
HPRD |
16873
|
IMGT |
|
EMBL |
AC004685
AC009132
AJ278219
AK058016
AK303878
BC002679
BC004263
BC017049
CH471114
|
GenPept |
AAC23496
AAH02679
AAH04263
AAH17049
BAB71632
BAH14072
CAC20436
EAW95678
|
|
|